{"id":"W2765485679","doi":"10.1158/1078-0432.ccr-17-2260","title":"A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in <i>PIK3CA</i> -Mutated Breast and Gynecologic Cancers","year":2017,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":146,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Jewish General Hospital","funders":"National Institute for Health and Care Research; Cancer Research UK; Astex Pharmaceuticals; Imperial Experimental Cancer Medicine Centre; AstraZeneca","keywords":"Medicine; Tolerability; Adverse effect; Common Terminology Criteria for Adverse Events; Pharmacodynamics; Pharmacokinetics; Dosing; Rash; Internal medicine; Nausea; Breast cancer; Oncology; Regimen; Phases of clinical research; Pharmacology; Toxicity; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001219757,0.001092887,0.001287813,0.0004054833,0.0004342723,0.0008550081,0.0007680085,0.001027172,0.003599385],"category_scores_gemma":[0.0006821156,0.000461908,0.0008086036,0.0003637546,0.0008433416,0.0008972039,0.0002608141,0.002881352,0.000764849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009356907,"about_ca_system_score_gemma":0.00188481,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000819725,"about_ca_topic_score_gemma":0.002570549,"domain_scores_codex":[0.9996763,0.000116373,0.00001745377,0.00007890898,0.00004381542,0.00006716553],"domain_scores_gemma":[0.9994566,0.00006555845,0.0001327193,0.00005170811,0.00004379776,0.0002495965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.551627,0.1593184,0.008910593,0.000819513,0.0008395162,0.0002681014,0.0003201293,0.003485421,0.1462597,0.0005450454,0.005670427,0.1219362],"study_design_scores_gemma":[0.3958833,0.5815202,0.008607139,0.00003599508,0.0002533591,0.0002401903,0.00005079418,0.001847268,0.008500257,0.0002339239,0.002798011,0.00002964833],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921347,0.0008855588,0.0009527221,0.0002788575,0.00009369506,0.003223909,0.001049654,0.00009620399,0.001284783],"genre_scores_gemma":[0.9869245,0.0009372128,0.003510148,0.0007476004,0.0001243854,0.003260496,0.002068103,0.00003366896,0.002393832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003599385,"threshold_uncertainty_score":0.01204109,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2654129356727883,"score_gpt":0.5986973071580772,"score_spread":0.3332843714852889,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}